Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pott

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2019
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 2014
Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphomaCindrilla Chumduri, Bernhard Gillissen, Anja Richter, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Cancer|April 22, 2011
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphomaSascha Dietrich, Blanca Tielesch, Michael Rieger, et al.
Trials|September 1, 2019
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trialLaila König, Martin Dreyling, Jan Dürig, et al.
Plos One|April 16, 2011
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomasLeandro Cerchietti, Christine Damm-Welk, Inga Vater, et al.
Haematologica|April 2, 2008
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsSebastian Böttcher, Matthias Ritgen, Sebastian Buske, et al.
British Journal of Haematology|October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL NetworkLinmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Frontiers in Cell and Developmental Biology|January 5, 2026
Association of fibronectin 1 deregulation with tyrosine kinase inhibitor resistance in chronic myeloid leukemiaLina Tiedemann, Sivahari Prasad Gorantla, Philine Ahlf, et al.
European Journal of Haematology|July 21, 2021
Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Christiane Pott, Thomas H Müller, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2019
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 2014
Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphomaCindrilla Chumduri, Bernhard Gillissen, Anja Richter, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Cancer|April 22, 2011
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphomaSascha Dietrich, Blanca Tielesch, Michael Rieger, et al.
Trials|September 1, 2019
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trialLaila König, Martin Dreyling, Jan Dürig, et al.
Plos One|April 16, 2011
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomasLeandro Cerchietti, Christine Damm-Welk, Inga Vater, et al.
Haematologica|April 2, 2008
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsSebastian Böttcher, Matthias Ritgen, Sebastian Buske, et al.
British Journal of Haematology|October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL NetworkLinmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Frontiers in Cell and Developmental Biology|January 5, 2026
Association of fibronectin 1 deregulation with tyrosine kinase inhibitor resistance in chronic myeloid leukemiaLina Tiedemann, Sivahari Prasad Gorantla, Philine Ahlf, et al.
European Journal of Haematology|July 21, 2021
Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Christiane Pott, Thomas H Müller, et al.
Pageof 12